Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Vertex Pharmaceuticals Inc
Recent news which mentions Vertex Pharmaceuticals Inc
Trump's pharmaceutical tariffs could affect some drugmakers more than others
July 29, 2025
Tags
Health & Science
Eli Lilly and Co
Vertex Pharmaceuticals Inc
From
CNBC.com News
Healthy Returns: Medicaid cuts in Trump’s megabill may affect some drugmakers more than others
July 08, 2025
Tags
Roche Holding AG
Health & Science
Social issues
From
CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
May 02, 2025
Tags
Shopify Inc
Mckesson Corp
Ford Motor Co
From
CNBC.com News
Trump's tariffs are a new challenge for Big Pharma. Here are the best positioned stocks
April 01, 2025
Tags
Vertex Pharmaceuticals Inc
AstraZeneca PLC
LILLY DRN
From
CNBC.com News
Jim Cramer says 'the market may be far healthier than we think.' Here's why
March 27, 2025
Tags
Vertex Pharmaceuticals Inc
CVS Health Corp
Investing
From
CNBC.com News
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
February 21, 2025
Tags
Business News
Pfizer Inc
Biotech and Pharmaceuticals
From
CNBC.com News
High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models
February 18, 2025
Tags
Health Insurance
Health insurance
Business News
From
CNBC.com News
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
January 30, 2025
Tags
Breaking News: Business
Biotech and Pharmaceuticals
Biotechnology
From
CNBC.com News
Cramer's Lightning Round: 'I would be a seller of QuantumScape'
January 08, 2025
Tags
Quantumscape Corp
Pfizer Inc
Business News
From
CNBC.com News
Cramer's Lightning Round: Vertex Pharmaceuticals is a buy
October 30, 2024
Tags
Investment Strategy
Stock Picks
Stock markets
From
CNBC.com News
Healthy Returns: Pfizer pulls sickle cell disease drug from markets – here’s why it matters
October 01, 2024
Tags
bluebird bio Inc
Health & Science
Vertex Pharmaceuticals Inc
From
CNBC.com News
Cramer's Lightning Round: Builders FirstSource 'can go higher'
August 28, 2024
Tags
Investment Strategy
Builders FirstSource Inc
Investment strategy
From
CNBC.com News
Cramer's Lighting Round: Vertex Pharmaceuticals is 'terrific'
April 08, 2024
Tags
Sibanye Stillwater Ltd
Markets
stocks
From
CNBC.com News
New sickle cell gene therapies are a breakthrough, but solving how to pay their high prices is a struggle
February 23, 2024
Tags
bluebird bio Inc
Health & Science
Eli Lilly and Co
From
CNBC.com News
Vertex non-opioid painkiller shows positive results in critical late-stage trial on acute pain
January 30, 2024
Tags
Pharmaceuticals
Health care industry
Health & Science
From
CNBC.com News
Vertex shares pop after non-opioid painkiller posts positive mid-stage trial results
December 13, 2023
Tags
Vertex
Biotechnology
Health & Science
From
CNBC.com News
U.S. approves first gene-editing treatment, Casgevy, for sickle cell disease
December 08, 2023
Tags
Business News
Government Agencies
Biotech and Pharmaceuticals
From
CNBC.com News
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
December 07, 2023
Tags
Biotech and Pharmaceuticals
Business News
Government Agencies
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
Bristol/Myers Squibb Co
Datadog Inc
Chevron Corp
From
CNBC.com News
20 stocks I'm watching in the market, including Emerson, DoorDash, Royal Caribbean
October 09, 2023
Tags
Markets
CNBC Investing Club: Newsletter
Breaking News: Markets
From
CNBC.com News
Cramer says Vertex has a drug that may address the 'largest market opportunity in the world'
October 09, 2023
Tags
CNBC Investing Club: Newsletter
Biotechnology
Markets
From
CNBC.com News
Cramer's Lightning Round: Vertex is 'excellent'
October 05, 2023
Tags
Under Armour Inc
Markets
Investing
From
CNBC.com News
Stocks making the biggest moves after hours: Arista Networks, MGM Resorts, Stryker and more
May 01, 2023
Tags
Stock markets
Business
Finance
From
CNBC.com News
Stocks making the biggest moves midday: Walgreens, Coinbase, Duolingo, Ralph Lauren and more
November 11, 2022
Tags
Citi Trends Inc
LegalZoom/com Inc
Duolingo Inc
From
CNBC.com News
Cramer's lightning round: Stay with Vertex Pharmaceuticals
October 27, 2022
Tags
Stock Picks
Stock markets
Investment strategy
From
CNBC.com News
Stocks making the biggest moves after hours: Amazon, Apple, Pinterest, Intel and more
October 27, 2022
Tags
Breaking news
Gilead Sciences Inc
U/S/ Markets
From
CNBC.com News
Jim Cramer says investors should eye these three tech names in the Nasdaq 100
July 05, 2022
Tags
Markets
DocuSign Inc
Vertex Pharmaceuticals Inc
From
CNBC.com News
Cramer's lightning round: I'm sticking with Marvell Technology
June 22, 2022
Tags
Business News
EOG Resources Inc
Investment Strategy
From
CNBC.com News
Stocks making the biggest moves midday: Global Payments, Moderna, Activision Blizzard and more
May 02, 2022
Tags
stocks
Breaking News: Markets
Johnson Controls International PLC
From
CNBC.com News
Some of the first quarter’s biggest losers could be the biggest steals, Jim Cramer says
April 04, 2022
Tags
IPG Photonics Corp
Stock markets
Mad Money
From
CNBC.com News
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.